Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 25, 2020
RFA-HL-20-021 - Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to alert potential applicants to a change in key dates for RFA-HL-20-021, "Trans-Agency Blood-Brain Interface Program (R61/R33 Clinical Trials Not Allowed)". Changes are shown in italics below.
Current dates:
|
Open Date (Earliest Submission Date) |
September 17, 2019 |
|
Letter of Intent Due Date(s) |
30 days prior to the application due date |
|
Application Due Date(s) |
December 2, 2019, October 19, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
AIDS Application Due Date(s) |
December 17, 2019, December 21, 2020 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
Scientific Merit Review |
February 2020, February 2021 |
|
Advisory Council Review |
May 2020, May 2021 |
|
Earliest Start Date |
September 2020, September 2021 |
|
Expiration Date |
December 22, 2021 |
Revised dates:
|
Open Date (Earliest Submission Date) |
June 24, 2020 |
|
Letter of Intent Due Date(s) |
30 days prior to the application due date |
|
Application Due Date(s) |
December 2, 2019, December 11, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
AIDS Application Due Date(s) |
December 17, 2019, December 21, 2020 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
Scientific Merit Review |
February 2020, February 2021 |
|
Advisory Council Review |
May 2020, May 2021 |
|
Earliest Start Date |
September 2020, September 2021 |
|
Expiration Date |
December 22, 2021 |
All other aspects of this FOA remain unchanged.
Margaret Ochocinska, PhD
Division of Blood Diseases and Research
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-827-8285
Email: [email protected]